Physician profile
Brian E Simmons
NPI 1851334973
$1,511.40
in general payments reported to CMS, 2019-2025
17 companies · $110 in 2025
The $110 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $971 · 2020: $141 · 2021: $152 · 2022: $41.61 · 2024: $95.98 · 2025: $110.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $206.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $518.56 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $238.93 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $165.10 | 2019-2020 | |
| Boston Scientific Corporation | $87.92 | 2019 | |
| Portola Pharmaceuticals, LLC | $87.60 | 2019 | |
| Abbott Laboratories | $74.48 | 2019-2020 | |
| Astellas Pharma US INC | $53.37 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $53.34 | 2019 | |
| Amarin Pharma, INC. | $45.31 | 2019 | |
| Medtronic Vascular, INC. | $43.98 | 2019-2020 | |
| Pfizer INC. | $38.06 | 2019 | |
| Amgen INC. | $28.25 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $25.97 | 2019 | |
| Mannkind Corporation | $18.31 | 2025 | |
| Sanofi-Aventis U.S. LLC | $14.26 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $10.87 | 2019 | |
| Z-Medica, LLC | $7.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Simmons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.